Cell MedX Corp. (CMXC) Financials Nov 14, 2014, 3:34 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Cell MedX Corp.
Fiscal year is June-May. All values USD millions. 2011 2012 2013 2014 5-year trend
Sales/Revenue - 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A - 0 0 0 0
COGS excluding D&A - 0 0 0 0
Depreciation & Amortization Expense - 0 0 0 0
Depreciation - 0 0 0 0
Amortization of Intangibles - 0 0 0 0
Gross Income - 0 0 0 0
2011 2012 2013 2014 5-year trend
SG&A Expense - 13,559 15,859 12,636 18,527
Research & Development - 0 0 - -
Other SG&A - 13,559 15,859 12,636 18,527
Other Operating Expense - 0 0 0 0
Unusual Expense - 0 0 0 0
EBIT after Unusual Expense - 0 0 0 0
Non Operating Income/Expense - 0 0 0 0
Non-Operating Interest Income - - - - -
Equity in Affiliates (Pretax) - 0 0 0 0
Interest Expense - 0 0 0 0
Gross Interest Expense - 0 0 0 0
Interest Capitalized - 0 0 0 0
Pretax Income - (13,559) (15,859) (12,636) (18,527)
Income Tax - 0 0 0 0
Income Tax - Current Domestic - 0 0 0 0
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic - - - - -
Income Tax - Deferred Foreign - - - - -
Income Tax Credits - - - - -
Equity in Affiliates - 0 0 0 0
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income - (13,559) (15,859) (12,636) (18,527)
Minority Interest Expense - 0 0 0 0
Net Income - (13,559) (15,859) (12,636) (18,527)
Extraordinaries & Discontinued Operations - 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations - 0 0 0 0
Net Income After Extraordinaries - (13,559) (15,859) (12,636) (18,527)
Preferred Dividends - 0 0 0 0
Net Income Available to Common - (13,559) (15,859) (12,636) (18,527)
EPS (Basic) - () () () ()
Basic Shares Outstanding - 31M 31M 31M 31M
EPS (Diluted) - () () () ()
Diluted Shares Outstanding - 31M 31M 31M 31M
EBITDA - (13,559) (15,859) (12,636) (18,527)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Cell MedX Corp.
Fiscal year is June-May. All values USD millions. 2011 2012 2013 2014 5-year trend
Sales/Revenue - 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A - 0 0 0 0
COGS excluding D&A - 0 0 0 0
Depreciation & Amortization Expense - 0 0 0 0
Depreciation - 0 0 0 0
Amortization of Intangibles - 0 0 0 0
Gross Income - 0 0 0 0
2011 2012 2013 2014 5-year trend
SG&A Expense - 13,559 15,859 12,636 18,527
Research & Development - 0 0 - -
Other SG&A - 13,559 15,859 12,636 18,527
Other Operating Expense - 0 0 0 0
Unusual Expense - 0 0 0 0
EBIT after Unusual Expense - 0 0 0 0
Non Operating Income/Expense - 0 0 0 0
Non-Operating Interest Income - - - - -
Equity in Affiliates (Pretax) - 0 0 0 0
Interest Expense - 0 0 0 0
Gross Interest Expense - 0 0 0 0
Interest Capitalized - 0 0 0 0
Pretax Income - (13,559) (15,859) (12,636) (18,527)
Income Tax - 0 0 0 0
Income Tax - Current Domestic - 0 0 0 0
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic - - - - -
Income Tax - Deferred Foreign - - - - -
Income Tax Credits - - - - -
Equity in Affiliates - 0 0 0 0
Other After Tax Income (Expense) - 0 0 0 0
Consolidated Net Income - (13,559) (15,859) (12,636) (18,527)
Minority Interest Expense - 0 0 0 0
Net Income - (13,559) (15,859) (12,636) (18,527)
Extraordinaries & Discontinued Operations - 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets - 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations - 0 0 0 0
Net Income After Extraordinaries - (13,559) (15,859) (12,636) (18,527)
Preferred Dividends - 0 0 0 0
Net Income Available to Common - (13,559) (15,859) (12,636) (18,527)
EPS (Basic) - () () () ()
Basic Shares Outstanding - 31M 31M 31M 31M
EPS (Diluted) - () () () ()
Diluted Shares Outstanding - 31M 31M 31M 31M
EBITDA - (13,559) (15,859) (12,636) (18,527)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
